receptor antagonist that displays selectivity over other receptors at concentrations up to 10 μ
M. A non-sedating antihistamine that inhibits histamine release and eosinophil chemotaxis during secondary phase allergic response. Inhibits activation of eosinophils, neutrophils and monocytes in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.
Campoli-Richards et al.
Cetirizine: actions on neurotransmitter receptors.
Snowman and Snyder
Effects of cetirizine on human eosinophil and neutrophil activation in vitro.
Walsh et al.
Int.Arch.Allergy Appl.Immunol., 1991;95:158
The citations listed below are publications that use Tocris products. Selected citations for Cetirizine dihydrochloride include:
Showing Results 1 - 3 of 3